This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Lifecycle Pharma, Inc.
Lifecycle Pharma, Inc., commonly referred to as Lifecycle Pharma, is a prominent biopharmaceutical company headquartered in the United States. Founded in the early 2000s, the company has established itself within the pharmaceutical industry, focusing on the development of innovative therapies for chronic diseases, particularly in the areas of respiratory and metabolic disorders. Lifecycle Pharma is renowned for its unique drug delivery systems and formulations, which enhance the efficacy and patient compliance of existing treatments. The company has achieved significant milestones, including successful clinical trials and partnerships that bolster its market position. With a commitment to advancing healthcare solutions, Lifecycle Pharma continues to make strides in improving patient outcomes through its specialised products and services.
DitchCarbon Score
How does Lifecycle Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lifecycle Pharma, Inc.'s score of 50 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Lifecycle Pharma, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Asahi Kasei Corporation, and any emissions data or climate commitments may be inherited from this parent organisation. Asahi Kasei Corporation, at the third cascade level, has established various climate initiatives, although specific reduction targets or achievements for Lifecycle Pharma, Inc. have not been detailed. The absence of documented reduction targets or climate pledges indicates that Lifecycle Pharma may still be in the process of developing its own sustainability strategies. In the context of the industry, Lifecycle Pharma, Inc. is expected to align with broader corporate climate commitments, potentially influenced by Asahi Kasei's sustainability goals. However, without specific emissions data or targets, it is challenging to assess the company's current carbon footprint or its commitment to reducing greenhouse gas emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | 0,000,000,000 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | - | 0,000,000,000 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lifecycle Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
